Jan 07, 2025 14:37
AEON - AEON Biopharma, Inc.
| Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
|---|---|---|---|---|---|---|---|
| 0.82 0.0 (0.0%) | --- | --- | 0.0 (0.35%) | -0.01 (-0.61%) | 0.02 (1.9%) | 0.01 (0.98%) | -0.02 (-1.81%) |
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.
Category:
PHARMACEUTICAL PREPARATIONS
Market Period:
Market
Earnings & Ratios
- Basic EPS:
- -0.6
- Diluted EPS:
- -0.6
- Basic P/E:
- -1.3666
- Diluted P/E:
- -1.3666
- RSI(14) 1m:
- 13.94
- VWAP:
- 0.82
- RVol:
Events
| Period | Kind | Movement | Occurred At |
|---|
Related News
Jan 04, 2025 01:02
Jul 16, 2024 09:51
May 29, 2024 13:35
May 09, 2024 13:35
May 03, 2024 11:00
Apr 19, 2024 13:55
Apr 01, 2024 19:02
Apr 01, 2024 17:47
Apr 01, 2024 14:39